0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Adenoid Cystic Carcinoma Alliance
a/k/a: ACCA
Address
PO Box 82
1649 N. Pacana Way
Green Valley, AZ 85614
USA
Phone
520-625-5495
Fax
951-609-3982
800 Number
--
TDD
--
The Adenoid Cystic Carcinoma Alliance (ACCA) was formed to raise awareness and disseminate information about this rare form of cancer. Our web site offers extensive disease information, personal stories, a support forum, patient database, and support funding for research projects. Adenoid cystic carcinoma is a rare form of cancer that usually begins in the head, neck or breast areas, but has been diagnosed in a variety of body sites.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
0-9 - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.
